Table 1 Characteristics of patients treated with CyberKnife for pelvic re-irradiation.
From: Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results
| Â | Number (%) | Mean (range) | Comments |
|---|---|---|---|
Patients | 16 | Â | Â |
   Sex (M/F) | 6 (37%)/10 (63%) |  |  |
   Age* | 55 | (34 - 70 y.o.) |  |
Primary disease | Â | Â | Â |
Anal canal | 6 (38%) | Â | Â |
Cervix | 4 (25%) | Â | Â |
Uterus | 1 (6%) | Â | Â |
Rectum | 4 (25%) | Â | Â |
Bladder | 1 (6%) | Â | Â |
Primary treatment | Â | Â | Â |
Surgery | 9 (56%) | Â | Â |
Chemotherapy | 13 (81%) | Â | 9 concomitant; 4 adjuvant |
Radiotherapy | 14 (87%) | Â | Â |
   Dose* |  | 45 Gy (20-75 Gy) |  |
   Eq D2* |  |  |  |
Early side effects (α/β = 3 Gy) |  | 45 Gy (33-58 Gy) |  |
Late side effects (α/β = 10 Gy) |  | 72 Gy (53-96 Gy) |  |
Treatment of the recurrence | Â | Â | Â |
Surgery | 6 (38%) | Â | Â |
Chemotherapy | 8 (50%) | Â | Â |
Radiotherapy | 3 (19%) | Â | Â |
   Dose* |  | 53.7 Gy (36-66 Gy) |  |
   Eq D2* |  |  |  |
Early side effects (α/β = 3 Gy) |  | 65 Gy (45-66 Gy) |  |
Late side effects (α/β = 10 Gy) |  | 106 Gy (72-110 Gy) |  |